Glycyrrhetinic Acid Mediated Drug Delivery Carriers for Hepatocellular Carcinoma Therapy

Molecular Pharmaceutics

Volumn 13, Issue 3, 2016, Pages 699-709

  Cai, Yuee ^a,b   Xu, Yingqi ^a,b   Chan, Hon Fai ^a   Fang, Xiaobin ^a   He, Chengwei ^a   Chen, Meiwan ^a  

^a University of Macau   (Macao)

^b Department of Earth and Environmental Sciences   (United States)

Author keywords

anti HCC; delivery systems; GA; liver targeting

Indexed keywords

DRUG CARRIER; GLYCYRRHETINIC ACID; LIPOSOME; NANOPARTICLE; ANTINEOPLASTIC AGENT;

ANTINEOPLASTIC ACTIVITY; ARTICLE; BIOLOGICAL ACTIVITY; DRUG BIOAVAILABILITY; DRUG DELIVERY SYSTEM; ENCAPSULATION; ENDOCYTOSIS; HUMAN; LIPOPHILICITY; LIVER CELL; LIVER CELL CARCINOMA; NONHUMAN; PRIORITY JOURNAL; TARGET CELL; ANIMAL; CARCINOMA, HEPATOCELLULAR; CHEMISTRY; LIVER NEOPLASMS;

ANIMALS; ANTINEOPLASTIC AGENTS; CARCINOMA, HEPATOCELLULAR; DRUG CARRIERS; DRUG DELIVERY SYSTEMS; GLYCYRRHETINIC ACID; HUMANS; LIVER NEOPLASMS;

EID: 84960104275     PISSN: 15438384     EISSN: 15438392     Source Type: Journal    
DOI: 10.1021/acs.molpharmaceut.5b00677     Document Type: Article

References (77)

1. Bruix, J.; Han, K. H.; Gores, G.; Llovet, J. M.; Mazzaferro, V. Liver cancer: Approaching a personalized care J. Hepatol. 2015, 62, S144-S156 10.1016/j.jhep.2015.02.007
2. Zhang, Z. M.; Lai, E. C.; Zhang, C.; Yu, H. W.; Liu, Z.; Wan, B. J.; Liu, L. M.; Tian, Z. H.; Deng, H.; Sun, Q. H.; Chen, X. P. The strategies for treating primary hepatocellular carcinoma with portal vein tumor thrombus Int. J. Surg. 2015, 20, 8 10.1016/j.ijsu.2015.05.009
3. Giunchedi, P.; Maestri, M.; Gavini, E.; Dionigi, P.; Rassu, G. Transarterial chemoembolization of hepatocellular carcinoma - agents and drugs: an overview. Part 2 Expert Opin. Drug Delivery 2013, 10, 799-810 10.1517/17425247.2013.796359
4. Demirjian, A.; Peng, P.; Geschwind, J. F.; Cosgrove, D.; Schutz, J.; Kamel, I. R.; Pawlik, T. M. Infiltrating hepatocellular carcinoma: seeing the tree through the forest J. Gastrointest Surg. 2011, 15, 2089-2097 10.1007/s11605-011-1614-7
5. Maluccio, M.; Covey, A. Recent progress in understanding, diagnosing, and treating hepatocellular carcinoma Ca-Cancer J. Clin. 2012, 62, 394-399 10.3322/caac.21161
6. Deng, G. L.; Zeng, S.; Shen, H. Chemotherapy and target therapy for hepatocellular carcinoma: New advances and challenges World J. Hepatol. 2015, 7, 787-798 10.4254/wjh.v7.i5.787
7. Bupathi, M.; Kaseb, A.; Meric-Bernstam, F.; Naing, A. Hepatocellular carcinoma: Where there is unmet need Mol. Oncol. 2015, 9 (8) 1501-1509 10.1016/j.molonc.2015.06.005
8. Chen, K. W.; Ou, T. M.; Hsu, C. W.; Horng, C. T.; Lee, C. C.; Tsai, Y. Y.; Tsai, C. C.; Liou, Y. S.; Yang, C. C.; Hsueh, C. W.; Kuo, W. H. Current systemic treatment of hepatocellular carcinoma: A review of the literature World J. Hepatol. 2015, 7, 1412-1420 10.4254/wjh.v7.i10.1412
9. Hu, Y.; Wang, S.; Wang, A.; Lin, L.; Chen, M.; Wang, Y. Antioxidant and hepatoprotective effect of Penthorum chinense Pursh extract against t-BHP-induced liver damage in L02 cells Molecules 2015, 20, 6443-6453 10.3390/molecules20046443
10. Marelli, U. K.; Rechenmacher, F.; Sobahi, T. R.; Mas-Moruno, C.; Kessler, H. Tumor Targeting via Integrin Ligands Front. Oncol. 2013, 3, 222 10.3389/fonc.2013.00222
11. Chintharlapalli, S.; Papineni, S.; Jutooru, I.; McAlees, A.; Safe, S. Structure-dependent activity of glycyrrhetinic acid derivatives as peroxisome proliferator-activated receptor {gamma} agonists in colon cancer cells Mol. Cancer Ther. 2007, 6, 1588-1598 10.1158/1535-7163.MCT-07-0022
12. Manns, M. P.; Wedemeyer, H.; Singer, A.; Khomutjanskaja, N.; Dienes, H. P.; Roskams, T.; Goldin, R.; Hehnke, U.; Inoue, H. Glycyrrhizin in patients who failed previous interferon alpha-based therapies: biochemical and histological effects after 52 weeks J. Viral Hepat. 2012, 19, 537-546 10.1111/j.1365-2893.2011.01579.x
13. Satomi, Y.; Nishino, H.; Shibata, S. Glycyrrhetinic acid and related compounds induce G1 arrest and apoptosis in human hepatocellular carcinoma HepG2 Anticancer Res. 2005, 25, 4043-4047
14. Tang, Z. H.; Li, T.; Chang, L. L.; Zhu, H.; Tong, Y. G.; Chen, X. P.; Wang, Y. T.; Lu, J. J. Glycyrrhetinic Acid triggers a protective autophagy by activation of extracellular regulated protein kinases in hepatocellular carcinoma cells J. Agric. Food Chem. 2014, 62, 11910-11916 10.1021/jf503968k
15. Hibasami, H.; Iwase, H.; Yoshioka, K.; Takahashi, H. Glycyrrhetic acid (a metabolic substance and aglycon of glycyrrhizin) induces apoptosis in human hepatoma, promyelotic leukemia and stomach cancer cells Int. J. Mol. Med. 2006, 17, 215-219 10.3892/ijmm.17.2.215
16. Kuang, P.; Zhao, W.; Su, W.; Zhang, Z.; Zhang, L.; Liu, J.; Ren, G.; Yin, Z.; Wang, X. 18beta-glycyrrhetinic acid inhibits hepatocellular carcinoma development by reversing hepatic stellate cell-mediated immunosuppression in mice Int. J. Cancer 2013, 132, 1831-1841 10.1002/ijc.27852
17. Wang, Y.; Du, H.; Zhai, G. Recent advances in active hepatic targeting drug delivery system Curr. Drug Targets 2014, 15, 573-599 10.2174/1389450115666140309232100
18. Zhou, X.; Zhang, M.; Yung, B.; Li, H.; Zhou, C.; Lee, L. J.; Lee, R. J. Lactosylated liposomes for targeted delivery of doxorubicin to hepatocellular carcinoma Int. J. Nanomed. 2012, 7, 5465-5474 10.2147/IJN.S33965
19. Wolschek, M. F.; Thallinger, C.; Kursa, M.; Rossler, V.; Allen, M.; Lichtenberger, C.; Kircheis, R.; Lucas, T.; Willheim, M.; Reinisch, W.; Gangl, A.; Wagner, E.; Jansen, B. Specific systemic nonviral gene delivery to human hepatocellular carcinoma xenografts in SCID mice Hepatology 2002, 36, 1106-1114 10.1053/jhep.2002.36372
20. Holmstrom, P.; Gafvels, M.; Eriksson, L. C.; Dzikaite, V.; Hultcrantz, R.; Eggertsen, G.; Stal, P. Expression of iron regulatory genes in a rat model of hepatocellular carcinoma Liver Int. 2006, 26, 976-985 10.1111/j.1478-3231.2006.01316.x
21. Niu, C.; Sun, Q.; Zhou, J.; Cheng, D.; Hong, G. Folate-functionalized polymeric micelles based on biodegradable PEG-PDLLA as a hepatic carcinoma-targeting delivery system Asian Pac. J. Cancer Prev. 2011, 12, 1995-1999
22. Parker, N.; Turk, M. J.; Westrick, E.; Lewis, J. D.; Low, P. S.; Leamon, C. P. Folate receptor expression in carcinomas and normal tissues determined by a quantitative radioligand binding assay Anal. Biochem. 2005, 338, 284-293 10.1016/j.ab.2004.12.026
23. Yan, J. J.; Liao, J. Z.; Lin, J. S.; He, X. X. Active radar guides missile to its target: receptor-based targeted treatment of hepatocellular carcinoma by nanoparticulate systems Tumor Biol. 2015, 36, 55-67 10.1007/s13277-014-2855-3
24. Negishi, M.; Irie, A.; Nagata, N.; Ichikawa, A. Specific binding of glycyrrhetinic acid to the rat liver membrane Biochim. Biophys. Acta, Biomembr. 1991, 1066, 77-82 10.1016/0005-2736(91)90253-5
25. Tian, Q.; Wang, X. H.; Wang, W.; Zhang, C. N.; Wang, P.; Yuan, Z. Self-assembly and liver targeting of sulfated chitosan nanoparticles functionalized with glycyrrhetinic acid Nanomedicine 2012, 8, 870-879 10.1016/j.nano.2011.11.002
26. Chen, J.; Jiang, H.; Wu, Y.; Li, Y.; Gao, Y. A novel glycyrrhetinic acid-modified oxaliplatin liposome for liver-targeting and in vitro/vivo evaluation Drug Des., Dev. Ther. 2015, 9, 2265-2275 10.2147/DDDT.S81722
27. Yan, G.; Chen, Q.; Xu, L.; Wei, H.; Ma, C.; Sun, Y. Preparation and evaluation of liver-targeting micelles loaded with oxaliplatin Artif. Cells, Nanomed., Biotechnol. 2014, 1-6 10.3109/21691401.2014.962747
28. Cheng, M.; Gao, X.; Wang, Y.; Chen, H.; He, B.; Xu, H.; Li, Y.; Han, J.; Zhang, Z. Synthesis of Glycyrrhetinic Acid-Modified Chitosan 5-Fluorouracil Nanoparticles and Its Inhibition of Liver Cancer Characteristics in Vitro and in Vivo Mar. Drugs 2013, 11, 3517-3536 10.3390/md11093517
29. Asl, M. N.; Hosseinzadeh, H. Review of pharmacological effects of Glycyrrhiza sp. and its bioactive compounds Phytother. Res. 2008, 22, 709-724 10.1002/ptr.2362
30. Shim, S. B.; Kim, N. J.; Kim, D. H. Beta-glucuronidase inhibitory activity and hepatoprotective effect of 18 beta-glycyrrhetinic acid from the rhizomes of Glycyrrhiza uralensis Planta Med. 2000, 66, 40-43 10.1055/s-2000-11109
31. Ara, C.; Massimi, M.; Conti Devirgiliis, L. Retinoic acid modulates gap junctional intercellular communication in hepatocytes and hepatoma cells Cell. Mol. Life Sci. 2002, 59, 1758-1765 10.1007/PL00012503
32. Carruba, G.; Cocciadiferro, L.; Bellavia, V.; Rizzo, S.; Tsatsanis, C.; Spandidos, D.; Muti, P.; Smith, C.; Mehta, P.; Castagnetta, L. Intercellular communication and human hepatocellular carcinoma Ann. N. Y. Acad. Sci. 2004, 1028, 202-212 10.1196/annals.1322.025
33. He, B.; Tong, X.; Wang, L.; Wang, Q.; Ye, H.; Liu, B.; Hong, X.; Tao, L.; Harris, A. L. Tramadol and flurbiprofen depress the cytotoxicity of cisplatin via their effects on gap junctions Clin. Cancer Res. 2009, 15 (18) 5803-5810 10.1158/1078-0432.CCR-09-0811
34. Zibara, K.; Awada, Z.; Dib, L.; El-Saghir, J.; Al-Ghadban, S.; Ibrik, A.; El-Zein, N.; El-Sabban, M. Anti-angiogenesis therapy and gap junction inhibition reduce MDA-MB-231 breast cancer cell invasion and metastasis in vitro and in vivo Sci. Rep. 2015, 5, 12598 10.1038/srep12598
35. Gumpricht, E.; Dahl, R.; Devereaux, M. W.; Sokol, R. J. Licorice compounds glycyrrhizin and 18beta-glycyrrhetinic acid are potent modulators of bile acid-induced cytotoxicity in rat hepatocytes J. Biol. Chem. 2005, 280, 10556-10563 10.1074/jbc.M411673200
36. Jeong, H. G.; You, H. J.; Park, S. J.; Moon, A. R.; Chung, Y. C.; Kang, S. K.; Chun, H. K. Hepatoprotective effects of 18beta-glycyrrhetinic acid on carbon tetrachloride-induced liver injury: inhibition of cytochrome P450 2E1 expression Pharmacol. Res. 2002, 46, 221-227 10.1016/S1043-6618(02)00121-4
37. Chen, S.; Zou, L.; Li, L.; Wu, T. The protective effect of glycyrrhetinic acid on carbon tetrachloride-induced chronic liver fibrosis in mice via upregulation of Nrf2 PLoS One 2013, 8, e53662 10.1371/journal.pone.0053662
38. Xia, S.; Tan, C.; Zhang, Y.; Abbas, S.; Feng, B.; Zhang, X.; Qin, F. Modulating effect of lipid bilayer-carotenoid interactions on the property of liposome encapsulation Colloids Surf., B 2015, 128, 172-180 10.1016/j.colsurfb.2015.02.004
39. Tian, J.; Wang, L.; Ke, X. A wogonin-loaded glycyrrhetinic acid-modified liposome for hepatic targeting with anti-tumor effects Drug Delivery 2014, 21, 553-559 10.3109/10717544.2013.853850
40. Mao, S. J.; Hou, S. X.; Jin, H.; Zhang, L. K.; Jiang, B. [Preparation of liposomes surface-modified with glycyrrhetinic acid targeting to hepatocytes] Zhongguo Zhongyao Zazhi 2003, 28, 328-331
41. Mao, S. J.; Bi, Y. Q.; Jin, H.; Wei, D. P.; He, R.; Hou, S. X. Preparation, characterization and uptake by primary cultured rat hepatocytes of liposomes surface-modified with glycyrrhetinic acid Pharmazie 2007, 62, 614-619
42. Li, J.; Xu, H.; Ke, X.; Tian, J. The anti-tumor performance of docetaxel liposomes surface-modified with glycyrrhetinic acid J. Drug Targeting 2012, 20, 467-473 10.3109/1061186X.2012.685475
43. Stefanutti, E.; Papacci, F.; Sennato, S.; Bombelli, C.; Viola, I.; Bonincontro, A.; Bordi, F.; Mancini, G.; Gigli, G.; Risuleo, G. Cationic liposomes formulated with DMPC and a gemini surfactant traverse the cell membrane without causing a significant bio-damage Biochim. Biophys. Acta, Biomembr. 2014, 1838, 2646-2655 10.1016/j.bbamem.2014.05.026
44. Karmali, P. P.; Chaudhuri, A. Cationic Liposomes as non-viral carriers of gene medicines: Resolved issues, open questions, and future promises Med. Res. Rev. 2007, 27, 696-722 10.1002/med.20090
45. He, Z. Y.; Zheng, X.; Wu, X. H.; Song, X. R.; He, G.; Wu, W. F.; Yu, S.; Mao, S. J.; Wei, Y. Q. Development of glycyrrhetinic acid-modified stealth cationic liposomes for gene delivery Int. J. Pharm. 2010, 397, 147-154 10.1016/j.ijpharm.2010.06.029
46. Tian, Y.; Mao, S. Amphiphilic polymeric micelles as the nanocarrier for peroral delivery of poorly soluble anticancer drugs Expert Opin. Drug Delivery 2012, 9, 687-700 10.1517/17425247.2012.681299
47. Torchilin, V. P. Structure and design of polymeric surfactant-based drug delivery systems J. Controlled Release 2001, 73, 137-172 10.1016/S0168-3659(01)00299-1
48. Wu, F.; Xu, T.; Liu, C.; Chen, C.; Song, X.; Zheng, Y.; He, G. Glycyrrhetinic Acid-Poly(ethylene glycol)-glycyrrhetinic Acid Tri-Block Conjugates Based Self-Assembled Micelles for Hepatic Targeted Delivery of Poorly Water Soluble Drug Sci. World J. 2013, 2013, 1 10.1155/2013/913654
49. Chen, Q.; Sun, Y.; Wang, J.; Yan, G.; Cui, Z.; Yin, H.; Wei, H. Preparation and characterization of glycyrrhetinic acid-modified stearic acid-grafted chitosan micelles Artif. Cells, Nanomed., Biotechnol. 2015, 43, 217 10.3109/21691401.2013.845570
50. Huang, W.; Wang, W.; Wang, P.; Zhang, C. N.; Tian, Q.; Zhang, Y.; Wang, X. H.; Cha, R. T.; Wang, C. H.; Yuan, Z. Glycyrrhetinic acid-functionalized degradable micelles as liver-targeted drug carrier J. Mater. Sci.: Mater. Med. 2011, 22, 853-863 10.1007/s10856-011-4262-2
51. Zhang, J.; Zhang, M.; Ji, J.; Fang, X.; Pan, X.; Wang, Y.; Wu, C.; Chen, M. Glycyrrhetinic Acid-Mediated Polymeric Drug Delivery Targeting the Acidic Microenvironment of Hepatocellular Carcinoma Pharm. Res. 2015, 32, 3376 10.1007/s11095-015-1714-2
52. Ouyang, C. P.; Liu, Q.; Zhao, S. X.; Ma, G. L.; Zhang, Z. P.; Song, C. X. Synthesis and characterization of star-shaped poly (lactide-co-glycolide) and its drug-loaded microspheres Polym. Bull. 2012, 68, 27-36 10.1007/s00289-011-0516-x
53. Zhang, Y.; Zhao, Q.; Shao, H. W.; Zhang, S. Y.; Han, X. Y. Synthesis and Characterization of Star-Shaped Block Copolymer sPCL-b-PEG-GA Adv. Mater. Sci. Eng. 2014, 2014, 1 10.1155/2014/107375
54. Kumari, P.; Ghosh, B.; Biswas, S. Nanocarriers for cancer-targeted drug delivery J. Drug Target. 2015, 1-13 10.3109/1061186X.2015.1051049
55. Rohilla, R.; Garg, T.; Bariwal, J.; Goyal, A. K.; Rath, G. Development, optimization and characterization of glycyrrhetinic acid-chitosan nanoparticles of atorvastatin for liver targeting Drug Delivery 2014, 1-8 10.3109/10717544.2014.977460
56. Tian, Q.; Zhang, C. N.; Wang, X. H.; Wang, W.; Huang, W.; Cha, R. T.; Wang, C. H.; Yuan, Z.; Liu, M.; Wan, H. Y.; Tang, H. Glycyrrhetinic acid-modified chitosan/poly(ethylene glycol) nanoparticles for liver-targeted delivery Biomaterials 2010, 31, 4748-4756 10.1016/j.biomaterials.2010.02.042
57. Yuan, R.; Zheng, F.; Zhong, S.; Tao, X.; Zhang, Y.; Gao, F.; Yao, F.; Chen, J.; Chen, Y.; Shi, G. Self-assembled nanoparticles of glycyrrhetic acid-modified pullulan as a novel carrier of curcumin Molecules 2014, 19, 13305-13318 10.3390/molecules190913305
58. Zhang, C.; Wang, W.; Liu, T.; Wu, Y.; Guo, H.; Wang, P.; Tian, Q.; Wang, Y.; Yuan, Z. Doxorubicin-loaded glycyrrhetinic acid-modified alginate nanoparticles for liver tumor chemotherapy Biomaterials 2012, 33, 2187-2196 10.1016/j.biomaterials.2011.11.045
59. Mezghrani, O.; Tang, Y.; Ke, X.; Chen, Y.; Hu, D.; Tu, J.; Zhao, L.; Bourkaib, N. Hepatocellular carcinoma dually-targeted nanoparticles for reduction triggered intracellular delivery of doxorubicin Int. J. Pharm. 2015, 478, 553-568 10.1016/j.ijpharm.2014.10.041
60. Zu, Y.; Meng, L.; Zhao, X.; Ge, Y.; Yu, X.; Zhang, Y.; Deng, Y. Preparation of 10-hydroxycamptothecin-loaded glycyrrhizic acid-conjugated bovine serum albumin nanoparticles for hepatocellular carcinoma-targeted drug delivery Int. J. Nanomed. 2013, 8, 1207-1222 10.2147/IJN.S40493
61. Qi, W. W.; Yu, H. Y.; Guo, H.; Lou, J.; Wang, Z. M.; Liu, P.; Sapin-Minet, A.; Maincent, P.; Hong, X. C.; Hu, X. M.; Xiao, Y. L. Doxorubicin-loaded glycyrrhetinic acid modified recombinant human serum albumin nanoparticles for targeting liver tumor chemotherapy Mol. Pharmaceutics 2015, 12, 675-683 10.1021/mp500394v
62. Tian, Z.; Yang, C.; Wang, W.; Yuan, Z. Shieldable tumor targeting based on pH responsive self-assembly/disassembly of gold nanoparticles ACS Appl. Mater. Interfaces 2014, 6, 17865-17876 10.1021/am5045339
63. Hou, J.; Shi, Q.; Cao, M.; Pan, P.; Ge, G.; Fan, X.; Bai, G.; Xin, Y. A novel approach for fluorescent visualization of glycyrrhetic acid on a cell with a quantum dot Biochemistry (Moscow) 2014, 79, 25-30 10.1134/S0006297914010040
64. Tian, Q.; Wang, X.; Wang, W.; Zhang, C.; Liu, Y.; Yuan, Z. Insight into glycyrrhetinic acid: The role of the hydroxyl group on liver targeting Int. J. Pharm. 2010, 400, 153-157 10.1016/j.ijpharm.2010.08.032
65. Luo, C.; Sun, J.; Sun, B.; He, Z. Prodrug-based nanoparticulate drug delivery strategies for cancer therapy Trends Pharmacol. Sci. 2014, 35, 556-566 10.1016/j.tips.2014.09.008
66. Cheng, M.; Gao, X.; Wang, Y.; Chen, H.; He, B.; Li, Y.; Han, J.; Zhang, Z. Synthesis of liver-targeting dual-ligand modified GCGA/5-FU nanoparticles and their characteristics in vitro and in vivo Int. J. Nanomed. 2013, 8, 4265-4276 10.2147/IJN.S52877
67. Guo, H.; Lai, Q.; Wang, W.; Wu, Y.; Zhang, C.; Liu, Y.; Yuan, Z. Functional alginate nanoparticles for efficient intracellular release of doxorubicin and hepatoma carcinoma cell targeting therapy Int. J. Pharm. 2013, 451, 1-11 10.1016/j.ijpharm.2013.04.025
68. Mariam, J.; Sivakami, S.; Dongre, P. M. Albumin corona on nanoparticles-a strategic approach in drug delivery Drug Delivery 2015, 1-9 10.3109/10717544.2015.1048488
69. Kubota, N.; Ohga, K.; Moriguchi, M. Permeability Properties of Glycol Chitosan Membrane Modified with Thiol-Groups J. Appl. Polym. Sci. 1991, 42, 495-501 10.1002/app.1991.070420222
70. Zhang, L.; Yao, J.; Zhou, J.; Wang, T.; Zhang, Q. Glycyrrhetinic acid-graft-hyaluronic acid conjugate as a carrier for synergistic targeted delivery of antitumor drugs Int. J. Pharm. 2013, 441, 654-664 10.1016/j.ijpharm.2012.10.030
71. Barenholz, Y. Doxil(R) - the first FDA-approved nano-drug: lessons learned J. Controlled Release 2012, 160, 117-134 10.1016/j.jconrel.2012.03.020
72. Bae, Y. H.; Park, K. Targeted drug delivery to tumors: myths, reality and possibility J. Controlled Release 2011, 153, 198-205 10.1016/j.jconrel.2011.06.001
73. Li, J.; Yu, H.; Li, S.; Wang, G. J. Enhanced distribution and extended elimination of glycyrrhetinic acid in mice liver by mPEG-PLA modified (mPEGylated) liposome J. Pharm. Biomed. Anal. 2010, 51, 1147-1153 10.1016/j.jpba.2009.11.005
74. Darvishi, B.; Manoochehri, S.; Esfandyari-Manesh, M.; Samadi, N.; Amini, M.; Atyabi, F.; Dinarvand, R. Enhanced Cellular Cytotoxicity and Antibacterial Activity of 18-beta-Glycyrrhetinic Acid by Albumin-conjugated PLGA Nanoparticles Drug Res. (Stuttgart, Ger.) 2015, 65, 617 10.1055/s-0034-1390487
75. Lin, J. H.; Wang, X. L.; Wu, Q.; Dai, J. D.; Guan, H. D.; Cao, W.; He, L. Y.; Wang, Y. R. Development of Salvianolic acid B-Tanshinone II A-Glycyrrhetinic acid compound liposomes: Formulation optimization and its effects on proliferation of hepatic stellate cells Int. J. Pharm. 2014, 462, 11-18 10.1016/j.ijpharm.2013.12.040
76. Galbiati, A.; Tabolacci, C.; Morozzo Della Rocca, B.; Mattioli, P.; Beninati, S.; Paradossi, G.; Desideri, A. Targeting Tumor Cells through Chitosan-Folate Modified Microcapsules Loaded with Camptothecin Bioconjugate Chem. 2011, 22, 1066-1072 10.1021/bc100546s
77. Zhao, X.; Liu, J.; Hu, Y.; Fan, Y.; Wang, D.; Yuan, J.; Xu, L.; Cui, L.; Jing, Z. Optimization on condition of glycyrrhetinic acid liposome by RSM and the research of its immunological activity Int. J. Biol. Macromol. 2012, 51, 299-304 10.1016/j.ijbiomac.2012.05.005